2.03 USD
+0.01 (+0.5%)
Last: Feb 6, 2026, 08:00 PM
ChartMill assigns a Buy % Consensus number of 85% to NAUT. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 2.55. This target is 25.62% above the current price.
- NAUT was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NAUT.
- In the previous month the buy percentage consensus was at a similar level.
- NAUT was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-05 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2024-06-27 | Guggenheim | Initiate | Buy |
| 2023-08-03 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2022-08-03 | Goldman Sachs | Maintains | Neutral |
| 2022-08-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-14 | Goldman Sachs | Maintains | Neutral |
| 2022-04-13 | Goldman Sachs | Maintains | Neutral |
| 2022-01-06 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-11-02 | Cowen & Co. | Initiate | Outperform |
| 2021-08-04 | Goldman Sachs | Initiate | Neutral |
| 2021-07-13 | Jefferies | Initiate | Buy |
NAUTILUS BIOTECHNOLOGY INC / NAUT FAQ
What is the price target for NAUT stock?
8 analysts have analysed NAUT and the average price target is 2.55 USD. This implies a price increase of 25.62% is expected in the next year compared to the current price of 2.03.
What is the consensus rating for NAUT stock?
The consensus rating for NAUTILUS BIOTECHNOLOGY INC (NAUT) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.